Florida Senate Bill 114, reflected on this page as the Florida S0114 update, is a proposal about what happens when a health insurer or HMO’s contract with a treating provider ends. It is not best understood as a generic insurance-dispute story. This bill is really about continuity of care, contract termination notices, and transition planning for patients who are in active treatment when a payer-provider relationship breaks down.
The official Senate bill page shows SB 114 was filed on October 7, 2025, referred to committee on October 13, 2025, and introduced on January 13, 2026. The public page does not show final passage or enactment. So the right way to use this article is as a practical guide to what the proposal would require if enacted, and what provider groups, health insurers, health systems, and compliance teams should be reviewing now if similar language advances.
What SB 114 Would Require
The filed Senate bill text is more specific than many short bill summaries suggest. It would add continuity obligations to insurer-provider and HMO-provider relationships in several important ways.
First, it would require advance notice to affected patients. The bill text would require a contract between a health insurer and a contracted health care practitioner to include a requirement that the insurer and practitioner issue a joint written notice at least 60 days before termination or cancellation of the contract. That notice would have to be written in plain language and include an explanation of the policyholder’s continuation-of-care rights, applicable timelines for transition, and contact information for questions or complaints.
Second, it would require ongoing care for certain active patients. The proposal says that when an insurer-provider contract is terminated, policyholders who were already in active treatment must be allowed to continue coverage and care until they select another treating practitioner or until the next open enrollment period offered by the organization, whichever is longer, but not longer than 6 months after termination. The bill also contains a special rule for prenatal care: a patient who has initiated prenatal care would be allowed to continue through completion of postpartum care.
Third, it would keep the terminated contract’s terms in place for that continuation period. That matters because continuity rules are only partly useful if reimbursement, participation, or operational terms disappear the moment the contract terminates. The bill would require the insurer and practitioner to remain bound by the terminated contract for care continued under the continuity provision.
Fourth, it would police last-minute contract changes. The bill text says changes made within 30 days before termination would be effective only if agreed to by both sides. That is a significant operational point for legal and contracting teams trying to manage end-of-relationship leverage.
Who Should Care Most About This Bill
Provider groups and health systems. Physician practices, clinics, hospitals, and provider organizations should read this bill as a contracting and operations issue. If enacted, it would affect provider termination workflows, patient notification practices, scheduling, reimbursement continuity, and front-desk scripts for patients caught in transition.
Health insurers and HMOs. Payers would need to evaluate template contract language, member notice workflows, call-center scripting, grievance intake, and systems for identifying which patients qualify as being in active treatment at the moment of network disruption.
Managed care and compliance teams. This bill is not just legal drafting. It would require implementation logic. Organizations would need to define how they identify affected patients, how they track notice deadlines, how they document compliance, and how they avoid inconsistent messaging to patients and providers.
Patients with active treatment needs. Patients are not the only audience, but they are the protected group at the center of the proposal. The bill is designed to reduce abrupt care disruptions for people who are in the middle of treatment, including pregnant patients whose continuity concerns are especially time-sensitive.
Why This Is Different From a Typical Insurance-Claim Dispute
Many insurance articles focus on denied benefits, underpayments, bad-faith conduct, or claim appeals. SB 114 is different. Its core problem is network disruption and continuity, not a single disputed claim file. The operational questions are therefore different too. Instead of asking whether a payer wrongfully denied a claim, stakeholders need to ask whether contract language, notice practices, and transition procedures protect patients who are already under care when the provider relationship changes.
That distinction is important for legal review. A provider dispute over reimbursement can quickly become a patient-transition problem if termination notices are late, incomplete, or inconsistent with contract language. Bills like SB 114 try to address that gap before it turns into broader patient harm or regulatory exposure.
Practical Implementation Questions If a Similar Measure Advances
How will active treatment be identified? Organizations would need a defensible definition for who qualifies for continuity protection at the time of termination.
Who owns the notice obligation? The bill calls for joint written notice in the insurer-provider context, which means contract templates and operational handoffs would need to be aligned before any termination event occurs.
What systems track the 60-day clock? Notice timing becomes a compliance problem if payer and provider systems are not synchronized.
How are prenatal patients handled? The proposal specifically protects ongoing prenatal care through postpartum care, so organizations would need a workflow that does not treat those patients like ordinary network-transition cases.
What happens to reimbursement terms during continuity care? The bill would keep the terminated contract binding for continued care, which makes careful contract inventory and termination planning essential.
Current Takeaway for Florida Health Care Organizations
As of the public record reflected on the Senate bill page, SB 114 should be treated as a proposal, not enacted law. Organizations should not assume they are already operating under these exact statutory requirements. But they also should not ignore the bill. Continuity-of-care legislation often highlights recurring pressure points that later surface in contracts, regulations, administrative guidance, or revised legislation.
For that reason, insurers, HMOs, medical groups, and counsel may want to use this proposal as a checklist for current risk review: Are notice clauses clear? Are continuity obligations addressed? Can the organization identify active-treatment patients quickly? Are termination events documented in a way that will hold up if challenged by regulators, patients, or contracting counterparties?
Bottom Line
SB 114 is best understood as a health care contracting and patient-transition bill. If enacted, it would require advance patient notice, preserve continuity of care for certain active-treatment patients, keep terminated contract terms in place during that continuation period, and impose special protections in contexts like prenatal care. But the official legislative page does not show final enactment, so stakeholders should read this as a proposal with real compliance implications if revived or advanced, not as a completed change to Florida law today.
Sources and Related Resources
Share your details and we’ll follow up shortly.
Frequently Asked Questions
Would SB 114 require a patient notice before a provider contract ends?
If enacted as filed, yes. The Senate bill text calls for joint written notice to affected policyholders at least 60 days before cancellation or termination of the contract.
Does this bill mainly deal with denied claims?
No. The bill is primarily about continuity of care when insurer-provider or HMO-provider relationships terminate, not about ordinary claim denials or underpayments.
Would active patients be allowed to keep seeing the same provider for a period of time?
If enacted, the bill would allow certain active-treatment patients to continue coverage and care until they select another provider or until the next open enrollment period, whichever is longer, up to 6 months, with special treatment for prenatal care through postpartum care.
